which company makes semaglutide Novo asks FDA to bar compounders from making copies Generic Semaglutide in USA (2026):

Discuss your preferences with the prescribing provider

Mounjaro is the first FDA approved dual agonist, meaning it activates both GLP-1 and GIP hormone pathways, which may confer additional weight lowering benefits

Most dont outright say its because theyre taking weight-loss medications, but in the comments of their social media posts, thats what their followers suspect

Corroborative information should be obtained from caregivers whenever possible

And while consistency is key to progress, let's be honestmonotony can be a motivation killer

Nausea, constipation, and mild headache are typical early side effects, usually resolving within 23 weeks